Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × sugemalimab × 1 year × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Standard of Care 158 Blood Specimen Collection 112 Practice Guidelines as Topic 101 Educational Status 101 Methods 95 Exercise 95 Interviews as Topic 94 Surveys and Questionnaires 89 Early Intervention, Educational 83 Magnetic Resonance Spectroscopy 70 Specimen Handling 65 Radiosurgery 58 Radiotherapy 50 Palliative Care 40 Control Groups 39 Patient Navigation 33 Drug Therapy 32 Therapeutics 30 Biopsy 29 Behavior Therapy 29 Counseling 28 Surgical Procedures, Operative 26 Resistance Training 26 Nutrition Assessment 26 Diet Therapy 25 Cognitive Behavioral Therapy 24 Acupuncture Therapy 24 Health Promotion 23 Exercise Test 22 Radiation 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07247227 2025-11-25

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Peking Union Medical College

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡